当前位置:首页 - 行情中心 - 立方制药(003020) - 财务分析

立方制药

(003020)

  

流通市值:30.45亿  总市值:42.29亿
流通股本:1.38亿   总股本:1.91亿

立方制药(003020)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.39亿元,每股收益0.20元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益195170.38万元,未分配利润97913.70万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产259605.85万元,负债64435.47万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入360,228,684.631,518,486,284.881,125,115,398.63769,332,113.02
营业总成本323,750,061.351,355,969,823.261,000,958,904.88682,320,390.82
营业利润44,108,590.09177,734,668.99131,563,699.4287,195,577.54
利润总额44,167,535.56171,815,971.97131,320,154.8386,943,206.65
净利润39,275,579.73152,480,813.62115,656,533.4875,992,607.41
其他综合收益----
综合收益总额39,275,579.73152,480,813.62115,656,533.4875,992,607.41
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计1,193,930,238.631,185,494,963.221,158,018,371.951,091,196,861.68
非流动资产合计1,402,128,258.71,400,480,350.891,396,805,593.891,392,707,684.25
资产总计2,596,058,497.332,585,975,314.112,554,823,965.842,483,904,545.93
流动负债合计557,260,557.59581,952,319.84537,803,723.7538,581,011.91
非流动负债合计87,094,150.1191,424,387.8392,359,472.6666,378,914.92
负债合计644,354,707.7673,376,707.67630,163,196.36604,959,926.83
归属于母公司股东权益合计1,775,966,833.091,737,886,950.361,731,705,401.751,692,406,398.87
股东权益合计1,951,703,789.631,912,598,606.441,924,660,769.481,878,944,619.1
负债和股东权益合计2,596,058,497.332,585,975,314.112,554,823,965.842,483,904,545.93
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计430,690,872.381,594,254,599.391,200,615,262.71772,837,780.92
经营活动现金流出小计394,629,659.071,396,721,856.621,073,938,500.05695,118,489.57
经营活动产生的现金流量净额36,061,213.31197,532,742.77126,676,762.6677,719,291.35
投资活动现金流入小计57,919,754.72381,384,215.65281,061,137.75178,245,654.55
投资活动现金流出小计76,948,231.6563,618,850.83516,033,237.1389,690,178.32
投资活动产生的现金流量净额-19,028,476.88-182,234,635.18-234,972,099.35-211,444,523.77
筹资活动现金流入小计1,00029,815,754.329,117,727.92465,514
筹资活动现金流出小计42,439,717.4108,147,500103,752,671.06101,762,662.94
筹资活动产生的现金流量净额-42,438,717.4-78,331,745.7-74,634,943.14-101,297,148.94
汇率变动对现金及现金等价物的影响-1,133.255,484.88-8,840.681,385.72
现金及现金等价物净增加额-25,407,114.22-63,028,153.23-182,939,120.51-235,020,995.64
期末现金及现金等价物余额411,484,493.62439,694,059.59319,783,092.31267,701,217.18
最新报告期:2025-05-30
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
山西证券魏赟1.111.471.942025-05-30
TOP↑